Experts agree that Vitamin C is one of the safest and most effective nutrients. We all know that Vitamin C is a powerful antioxidant with abundant benefits including immune enhancement, protection from viruses and bacteria, cardiovascular protection, eye diseases and even skin wrinkles. What many people may not know, however, is that in high-dose IV Vitamin C, Vitamin C can kill cancer cells.
When taken orally in recommended doses, Vitamin C acts as an antioxidant destroying free radicals. However, the high doses that can be attained through intravenous infusion have a different action within the body. Vitamin C works with metals in the body to create hydrogen peroxide. Whereas normal cells have the ability to reduce the effects of hydrogen peroxide, cancer cells do not. The high concentration of the resulting hydrogen peroxide damages the DNA of the cancer cells, cuts off their energy supply and kills them. Vitamin C, even in very high doses, is toxic only to the cancer cells without harming the healthy cells.
The earliest experience of using high-dose vitamin C for cancer treatment was by a Scottish surgeon, Ewan Cameron, and his colleague, Allan Campbell, in the 1970s. This work led to a collaboration between Cameron and the Nobel Prize–winning chemist Linus Pauling, further promoting the potential of vitamin C therapy in cancer management. The results clearly indicate that this simple and safe form of medication is of definite value in the treatment of patients with advanced cancer. You can read these studies by clicking on the links in the research enumerated below.
So if Vitamin C is so great at fighting cancer, why isn’t the medical industry embracing it? One of the biggest hurdles is the critics pointing to the lack of controlled double-blind studies demonstrating Vitamin C’s efficacy in treating cancer. Double-blind studies are typically conducted by pharmaceutical companies. The studies are huge undertakings and prohibitively expensive. Vitamin C is a naturally occurring nutrient that cannot be patented and, therefore, drug companies are not willing to sponsor the research. Moreover, the billion-dollar cancer drug industry does not want to prove that a naturally occurring Vitamin is more effective than their drugs. They would be putting themselves out of business. And don’t forget, cancer is a very big business.
This is not to say that legitimate research has not been performed that demonstrates the curative effects of Vitamin C on many diseases including cancer. If you perform a search in PubMed, a government research database, you will find over 50,000 remarkable studies on Vitamin C. We have provided links to some of these studies below so that you can read this research yourself and feel confident that substantial evidence exists supporting the use of Vitamin C in cancer treatment. Western medicine should be ashamed of itself for ignoring this truth and depriving their patients from these benefits.
Another lie critics point to is that Vitamin C is not safe. That is absolutely not true. Vitamin C has been used successfully for over 70 years without a single confirmed report of any dose, even a mega-dose, causing any significant harm on an individual. Yet, according to the Journal of the American Medical Association, approximately 100,000 patients died in hospitals in 1994 from legally prescribed and carefully supervised medications and that number has remained constant every year since.
Utopia Wellness recognizes the benefits of high-dose IV Vitamin C and has administered thousands of therapies without incident. We believe there is substantial evidence that points to the benefits of High Dose Vitamin C Therapy for patients with cancer. Therefore, we offer this therapy as part of our cancer treatment program.
We have many cancer patients email us asking if they can get the same benefit by taking high doses of Vitamin C orally. Unfortunately the answer is no. The only way to get the blood levels of Vitamin C high enough to kill cancer cells is to administer it intravenously. Our intestinal tract limits the amount of Vitamin C we can absorb and is not tolerated by our digestive system at these levels. Even if you ingested only 10 g of vitamin C, you would only absorb approximately 5% (.5g) and would certainly develop a pretty severe case of diarrhea. Vitamin C administered intravenously has the benefit of bypassing this control system and you absorb 100% of the intake. Moreover, it does not cause stomach upset or diarrhea.
High dose vitamin C is contraindicated in patients with an iron overload disease. It is also contraindicated in patients with renal insufficiency or renal failure, or those undergoing dialysis.
*Disclaimer: Individual patient results may vary based on a patient’s medical history and other factors. Information on this site is not intended to replace the advice of your physician or healthcare provider. Statements made about products, therapies or services have not been evaluated by the Food and Drug Administration.
Studies demonstrating the benefits of high-dose Vitamin C:
- Cameron E, Campbell A: The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 9 (4): 285-315, 1974. [PUBMED Abstract]
- Cameron E, Pauling L: Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 73 (10): 3685-9, 1976. [PUBMED Abstract]
- Cameron E, Pauling L: Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 75 (9): 4538-42, 1978. [PUBMED Abstract]
- Epigenetic reprogramming of melanoma cells by vitamin C treatment. Gustafson CB1, Yang C2, Dickson KM1, Shao H3, Van Booven D1, Harbour JW4, Liu ZJ5, Wang G
- Chen P, Stone J, Sullivan G, et al.: Anti-cancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models. Free Radic Biol Med 51 (3): 681-7, 2011. [PUBMED Abstract]
- Chen Q, Espey MG, Krishna MC, et al.: Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A 102 (38): 13604-9, 2005. [PUBMED Abstract]
- Verrax J, Calderon PB: Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects. Free Radic Biol Med 47 (1): 32-40, 2009. [PUBMED Abstract]
- Chen Q, Espey MG, Sun AY, et al.: Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A 105 (32): 11105-9, 2008. [PUBMED Abstract]
- Frömberg A, Gutsch D, Schulze D, et al.: Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs. Cancer Chemother Pharmacol 67 (5): 1157-66, 2011. [PUBMED Abstract]
- Chen P, Yu J, Chalmers B, et al.: Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy. Anticancer Drugs 23 (4): 437-44, 2012. [PUBMED Abstract]
- Du J, Martin SM, Levine M, et al.: Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res 16 (2): 509-20, 2010. [PUBMED Abstract]
- Espey MG, Chen P, Chalmers B, et al.: Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med 50 (11): 1610-9, 2011. [PUBMED Abstract]
- Lin ZY, Chuang WL: Pharmacologic concentrations of ascorbic acid cause diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines. Biomed Pharmacother 64 (5): 348-51, 2010. [PUBMED Abstract]
- Pathi SS, Lei P, Sreevalsan S, et al.: Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells. Nutr Cancer 63 (7): 1133-42, 2011. [PUBMED Abstract]
- Takemura Y, Satoh M, Satoh K, et al.: High dose of ascorbic acid induces cell death in mesothelioma cells. Biochem Biophys Res Commun 394 (2): 249-53, 2010. [PUBMED Abstract]
- Hardaway CM, Badisa RB, Soliman KF: Effect of ascorbic acid and hydrogen peroxide on mouse neuroblastoma cells. Mol Med Report 5 (6): 1449-52, 2012. [PUBMED Abstract]
The studies on high-dose Vitamin C are too extensive to list them all here. If you would like to read more, visit PubMed and enter the search term: high dose vitamin c + cancer.
Disclaimer: Statements made about products, therapies or services have not been evaluated by the Food and Drug Administration. Use of this Web site does not create an expressed or implied physician-patient relationship. In using this website you agree that neither Utopia Wellness nor any other party is or will be liable or otherwise responsible for any decision made or any action taken or any action not taken due to your use of any information presented at this website.